Capivasertib
Capivasertib (AZD5363) is an orally active and potent pan-AKT kinase inhibitor with IC50 of 3, 7 and 7 nM for Akt1, Akt2 and Akt3, respectively.
Product Specifications
CAS Number
1143532-39-1
Product Name Alternative
AZD5363
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Akt; Autophagy
Type
Reference compound
Related Pathways
Autophagy; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AZD5363.html
Purity
99.96
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO
Molecular Formula
C21H25ClN6O2
Molecular Weight
428.92
Precautions
H302, H315, H319, H335
References & Citations
[1]Davies BR, et al. Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background. Mol Cancer Ther. 2012 Apr;11 (4) :873-87.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Akt1; Akt2; Akt3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
376401 500 µg
HLADRa (Human Leukocyte Antigen DR, alpha Subunit) discontinued
Sign In for Pricing
View Details LV737585 1.0 µg DNA
OR5AN2P Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details MBS093843 Inquire
Pigeon Serine/Threonine-Protein Kinase GSK3A (GSK3A)
Sign In for Pricing
View Details